Nyxoah SA

NASDAQ:NYXH

5.24

-0.31 (-5.59%)

6:19:24 PM EDT: $5.24 0.00 (0.00%)

Market Cap (Intraday)	185.17M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.26 Million
Adjusted EPS	-$0.68

See more estimates

10-Day MA	$5.73
50-Day MA	$6.95
200-Day MA	$8.03

See more pivots

Nyxoah SA Stock, NASDAQ:NYXH

Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435

Belgium

Phone: +32.10.22.23.55

Number of Employees: 146.8

http://www.nyxoah.com

Description

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.